• Hlavní
  • Analytika
  • Zprávy z trhu
  • Company news: Johnson & Johnson (JNJ) quarterly results beat analysts’ forecasts
Ekonomické zprávy
18.04.2023

Company news: Johnson & Johnson (JNJ) quarterly results beat analysts’ forecasts

Johnson & Johnson (JNJ) reported Q1 FY2023 earnings of $2.68 per share (versus $2.67 per share in Q1 FY2022), beating analysts’ consensus estimate of $2.50 per share.

The company’s quarterly revenues amounted to $24.746 bln (+5.6% y/y), beating analysts’ consensus estimate of $23.610 bln.

The company also raised its FY2023 EPS guidance to $10.60-10.70, up from its prior guidance of $10.40-10.60, versus analysts’ consensus estimate of $10.51, and increased its FY2023 revenues guidance to +5.5-6.5% y/y to $97.9-98.9 bln, up from prior guidance of $96.9-97.9 bln, versus analysts’ consensus estimate of $97.65 bln.

JNJ rose to $168.74 (+1.85%) in pre-market trading.

 

Podívejte se také